Skip to main content
. 2016 Nov 13;2016:9302537. doi: 10.1155/2016/9302537

Table 2.

Expression of MSC markers of ADHLSCs and comparison with BM-MSC and ASC.

Markers ADHLSC BM-MSC [14, 15] ASC [15]
CD73 98.3% (95.0–99.7) ≥95% (guideline) ≥95%
CD90 91.5% (86.9–95.0) ≥95% (guideline) ≥95%
CD105 96.7% (93.8–99.6) ≥95% (guideline) ≥95%
CD11b 0.7% (0.0–2.0) ≤2% (guideline) ≤2%
CD14 2.0% (0.0–3.26) ≤2% (guideline) ≤2%
CD19 0.5% (0.0–2.0) ≤2% (guideline) ≤2%
CD45 1.1% (0.0–2.8) ≤2% (guideline) ≤2%
HLA-DR 0.8%  ± 0.5 ≤2% (guideline) ≤2%

CD34 1.3% (0.1–2.6) 0.1% (0.0−0.1) 9.0% (5.1–30.1)
CD36 3.5% (0.0–12.0) 0.1% (0.0−0.2) 11.5% (4.8–13.4)
CD91 0.7% (0.0−1.7) N.D. 47.6% (12.7–87.4)
CD140b 93.8% (99.4–78.6) 54.3% (45.9–87.5) 79.9% (49.2–87.5)
CD141 7.2% (4.2–12.8) N.D. ≥95%
CD201 53.3% (0.17–81.1) 2.0% (1.8–4.8) 13.6% (9.5–25.6)